Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic.

Givi B, Schiff BA, Chinn SB, Clayburgh D, Iyer NG, Jalisi S, Moore MG, Nathan CA, Orloff LA, O'Neill JP, Parker N, Zender C, Morris LGT, Davies L.

JAMA Otolaryngol Head Neck Surg. 2020 Mar 31. doi: 10.1001/jamaoto.2020.0780. [Epub ahead of print]

PMID:
32232423
2.

Apoptosis signaling molecules as treatment targets in head and neck squamous cell carcinoma.

Ow TJ, Thomas C, Fulcher CD, Chen J, López A, Reyna DE, Prystowsky MB, Smith RV, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Schlecht NF, Gavathiotis E.

Laryngoscope. 2020 Jan 2. doi: 10.1002/lary.28441. [Epub ahead of print]

PMID:
31894587
3.

Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population.

Liao DZ, Schlecht NF, Rosenblatt G, Kinkhabwala CM, Leonard JA, Ference RS, Prystowsky MB, Ow TJ, Schiff BA, Smith RV, Mehta V.

JAMA Otolaryngol Head Neck Surg. 2019 Sep 12. doi: 10.1001/jamaoto.2019.2414. [Epub ahead of print]

PMID:
31513264
4.

The safety and efficacy of open bedside tracheotomy: A retrospective analysis of 1000 patients.

Liao DZ, Mehta V, Kinkhabwala CM, Li D, Palsen S, Schiff BA.

Laryngoscope. 2019 Aug 12. doi: 10.1002/lary.28234. [Epub ahead of print]

PMID:
31403711
5.

Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2019 Aug 1;25(15):4862. doi: 10.1158/1078-0432.CCR-19-2052. No abstract available.

PMID:
31371312
6.

Response to Confounding Factors on the Prediction of Opioid Usage after Thyroidectomy and Parathyroidectomy Surgery.

Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V.

Otolaryngol Head Neck Surg. 2019 Aug;161(2):371-372. doi: 10.1177/0194599819841607. No abstract available.

PMID:
31369346
7.

Comparison of Bethesda cytopathology classification to surgical pathology across racial-ethnic groups.

Bresler A, Mehta V, Schiff BA, Smith RV, Khader S, Ramos-Rivera G, Lin J, Libutti SK, Laird AM, Ow TJ.

Head Neck. 2019 Jul;41(7):2340-2345. doi: 10.1002/hed.25707. Epub 2019 Feb 21.

PMID:
30793405
8.

Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1.

Ow TJ, Fulcher CD, Thomas C, Broin PÓ, López A, Reyna DE, Smith RV, Sarta C, Prystowsky MB, Schlecht NF, Schiff BA, Rosenblatt G, Belbin TJ, Harris TM, Childs GC, Kawachi N, Guha C, Gavathiotis E.

Oncotarget. 2019 Jan 11;10(4):494-510. doi: 10.18632/oncotarget.26563. eCollection 2019 Jan 11.

9.

Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.

Mehta V, Ow TJ, Kim S, Tharakan T, Schiff B, Smith RV, In H.

Head Neck. 2019 May;41(5):1403-1411. doi: 10.1002/hed.25596. Epub 2019 Jan 16.

PMID:
30652370
10.

Postoperative Pain Control and Opioid Usage Patterns among Patients Undergoing Thyroidectomy and Parathyroidectomy.

Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V.

Otolaryngol Head Neck Surg. 2019 Mar;160(3):394-401. doi: 10.1177/0194599818797574. Epub 2018 Oct 16.

11.

Enseigner l’aide médicale à mourir aux résidents.

Wiebe E, Green S, Schiff B.

Can Fam Physician. 2018 Apr;64(4):e199-e200. French. No abstract available.

PMID:
29650622
Free PMC Article
12.

Teaching residents about medical assistance in dying.

Wiebe E, Green S, Schiff B.

Can Fam Physician. 2018 Apr;64(4):315-316. No abstract available.

13.

Preoperative 18F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell Carcinoma.

Cho JK, Ow TJ, Lee AY, Smith RV, Schlecht NF, Schiff BA, Tassler AB, Lin J, Moadel RM, Valdivia A, Abraham T, Gulko E, Neimark M, Ustun B, Bello JA, Shifteh K.

Otolaryngol Head Neck Surg. 2017 Sep;157(3):439-447. doi: 10.1177/0194599817703927. Epub 2017 Jun 13.

14.

The Relationship between Body Mass, Tracheal Diameter, Endotracheal Tube Size, and Tracheal Stenosis.

Schiff BA.

Int Anesthesiol Clin. 2017 Fall;55(1):42-51. Review. No abstract available.

PMID:
27930416
15.

Tumor Debulking in the Management of Laryngeal Cancer Airway Obstruction.

Du E, Smith RV, Ow TJ, Tassler AB, Schiff BA.

Otolaryngol Head Neck Surg. 2016 Nov;155(5):805-807. Epub 2016 Jul 26.

PMID:
27459956
16.

Minimal Margin Extracapsular Dissection: A Viable Alternative Technique for Benign Parotid Lesions?

McMullen CP, Smith RV, Ow TJ, Tassler A, Schiff BA.

Ann Otol Rhinol Laryngol. 2016 Nov;125(11):912-917. Epub 2016 Jul 25.

PMID:
27456086
17.

How radiologic/clinicopathologic features relate to compressive symptoms in benign thyroid disease.

Siegel B, Ow TJ, Abraham SS, Loftus PA, Tassler AB, Smith RV, Schiff BA.

Laryngoscope. 2017 Apr;127(4):993-997. doi: 10.1002/lary.26124. Epub 2016 Jul 20.

PMID:
27438354
18.

Refining the utility and role of Frozen section in head and neck squamous cell carcinoma resection.

Du E, Ow TJ, Lo YT, Gersten A, Schiff BA, Tassler AB, Smith RV.

Laryngoscope. 2016 Aug;126(8):1768-75. doi: 10.1002/lary.25899. Epub 2016 Apr 26.

PMID:
27113207
19.

Use of computed tomography to assess volume change after endoscopic orbital decompression for Graves' ophthalmopathy.

Schiff BA, McMullen CP, Farinhas J, Jackman AH, Hagiwara M, McKellop J, Lui YW.

Am J Otolaryngol. 2015 Nov-Dec;36(6):729-35. doi: 10.1016/j.amjoto.2015.06.005. Epub 2015 Jun 23.

PMID:
26545461
20.

Randomized Controlled Trial Assessing the Feasibility of Shortened Fasts in Intubated ICU Patients Undergoing Tracheotomy.

Gonik N, Tassler A, Ow TJ, Smith RV, Shuaib S, Cohen HW, Sarta C, Schiff BA.

Otolaryngol Head Neck Surg. 2016 Jan;154(1):87-93. doi: 10.1177/0194599815611859. Epub 2015 Oct 12.

PMID:
26459247
21.

The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.

Smith RV, Schiff BA, Garg M, Haigentz M.

Laryngoscope. 2015 Nov;125 Suppl 10:S1-S15. doi: 10.1002/lary.25534. Epub 2015 Oct 5.

PMID:
26436491
22.

Transoral Robotic Surgery in Oropharyngeal Carcinoma.

Helman SN, Schwedhelm T, Kadakia S, Wang Y, Schiff BA, Smith RV.

Arch Pathol Lab Med. 2015 Nov;139(11):1389-97. doi: 10.5858/arpa.2014-0573-RA. Epub 2015 Aug 19. Review.

PMID:
26288397
23.

Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.

Hakima L, Adler E, Prystowsky M, Schiff B, Schlecht N, Fox A, Suhrland M, Khader SN.

Diagn Cytopathol. 2015 Sep;43(9):683-7. doi: 10.1002/dc.23278. Epub 2015 May 12.

PMID:
25964135
24.

Superficial temporal artery and vein as recipient vessels for scalp and facial reconstruction: radiographic support for underused vessels.

Doscher M, Charafeddine AH, Schiff BA, Miller T, Smith RV, Tepper O, Garfein ES.

J Reconstr Microsurg. 2015 May;31(4):249-53. doi: 10.1055/s-0034-1394160. Epub 2015 Jan 28.

PMID:
25629208
25.

Introduction: Development's story in time and place.

Schiff B.

New Dir Child Adolesc Dev. 2014 Fall;2014(145):1-13. doi: 10.1002/cad.20063.

PMID:
25251506
26.

Combined P16 and human papillomavirus testing predicts head and neck cancer survival.

Salazar CR, Anayannis N, Smith RV, Wang Y, Haigentz M Jr, Garg M, Schiff BA, Kawachi N, Elman J, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF.

Int J Cancer. 2014 Nov 15;135(10):2404-12. doi: 10.1002/ijc.28876. Epub 2014 Apr 17.

27.

Risk factors for perioperative airway difficulty and evaluation of intubation approaches among patients with benign goiter.

Loftus PA, Ow TJ, Siegel B, Tassler AB, Smith RV, Schiff BA.

Ann Otol Rhinol Laryngol. 2014 Apr;123(4):279-85. doi: 10.1177/0003489414524171. Epub 2014 Mar 4. Erratum in: Ann Otol Rhinol Laryngol. 2014 Apr;123(4):279-85. Cohen, Hillel W [removed].

PMID:
24595624
28.

Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage.

Koss SL, Russell MD, Leem TH, Schiff BA, Smith RV.

Laryngoscope. 2014 Feb;124(2):421-8. doi: 10.1002/lary.24005. Epub 2013 Dec 9.

PMID:
24323309
29.

Intraoperative inflation of laryngocele with LMA.

Gonik N, Setty S, Delphin E, Straker T, Schiff BA.

Am J Otolaryngol. 2013 Nov-Dec;34(6):746-8. doi: 10.1016/j.amjoto.2013.07.012. Epub 2013 Sep 9.

PMID:
24028977
30.

Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.

Salazar CR, Smith RV, Garg MK, Haigentz M Jr, Schiff BA, Kawachi N, Anayannis N, Belbin TJ, Prystowsky MB, Burk RD, Schlecht NF.

Head Neck Pathol. 2014 Mar;8(1):77-87. doi: 10.1007/s12105-013-0486-4. Epub 2013 Sep 4.

31.

Tracheal invasion and perforation from advanced primary thyroid lymphoma: a case report and literature review.

Chen C, Tibbetts KM, Tassler AB, Schiff BA.

Am J Otolaryngol. 2013 Sep-Oct;34(5):559-62. doi: 10.1016/j.amjoto.2013.04.004. Epub 2013 May 20. Review.

PMID:
23702317
32.

Transoral robotic total laryngectomy.

Smith RV, Schiff BA, Sarta C, Hans S, Brasnu D.

Laryngoscope. 2013 Mar;123(3):678-82. doi: 10.1002/lary.23842. Epub 2013 Jan 8.

PMID:
23299907
33.

Salivary mucoepidermoid carcinoma: a multi-institutional review of 76 patients.

Bai S, Clubwala R, Adler E, Sarta C, Schiff B, Smith RV, Gnepp DR, Brandwein-Gensler M.

Head Neck Pathol. 2013 Jun;7(2):105-12. doi: 10.1007/s12105-012-0405-0. Epub 2012 Oct 19.

34.

Criterion-based (proficiency) training to improve surgical performance.

Fried MP, Kaye RJ, Gibber MJ, Jackman AH, Paskhover BP, Sadoughi B, Schiff B, Fraioli RE, Jacobs JB.

Arch Otolaryngol Head Neck Surg. 2012 Nov 1;138(11):1024-9. doi: 10.1001/2013.jamaoto.377.

PMID:
23069788
35.

Transoral robotic reconstructive surgery reconstruction of a tongue base defect with a radial forearm flap.

Garfein ES, Greaney PJ Jr, Easterlin B, Schiff B, Smith RV.

Plast Reconstr Surg. 2011 Jun;127(6):2352-4. doi: 10.1097/PRS.0b013e318213a0e4. No abstract available.

PMID:
21617469
36.

Otolaryngology resident selection: do rank lists matter?

Bent JP, Colley PM, Zahtz GD, Smith RV, Parikh SR, Schiff B, Fried MP.

Otolaryngol Head Neck Surg. 2011 Apr;144(4):537-41. doi: 10.1177/0194599810396604. Epub 2011 Feb 4.

PMID:
21493231
37.

Open bedside tracheotomy: impact on patient care and patient safety.

Yoo DB, Schiff BA, Martz S, Fraioli RE, Smith RV, Kvetan V, Fried MP.

Laryngoscope. 2011 Mar;121(3):515-20. doi: 10.1002/lary.21413. Epub 2011 Feb 4.

PMID:
21298643
38.

Importance of computer-aided design and manufacturing technology in the multidisciplinary approach to head and neck reconstruction.

Sharaf B, Levine JP, Hirsch DL, Bastidas JA, Schiff BA, Garfein ES.

J Craniofac Surg. 2010 Jul;21(4):1277-80. doi: 10.1097/SCS.0b013e3181e1b5d8.

PMID:
20613609
39.

Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma.

Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, Schiff B, Owen RP, Smith J, Sarta C, Hebert T, Nason R, Ramer M, DeLacure M, Hirsch D, Myssiorek D, Heller K, Prystowsky M, Schlecht NF, Negassa A.

Am J Surg Pathol. 2010 May;34(5):676-88. doi: 10.1097/PAS.0b013e3181d95c37.

PMID:
20414102
40.

Mentoring in otolaryngology training programs.

Gurgel RK, Schiff BA, Flint JH, Miller RA, Zahtz GD, Smith RV, Fried MP, Smith RJ.

Otolaryngol Head Neck Surg. 2010 Apr;142(4):487-92. doi: 10.1016/j.otohns.2009.12.002.

PMID:
20304265
41.

Head and neck cancer: reduce and integrate for optimal outcome.

Belbin TJ, Bergman A, Brandwein-Gensler M, Chen Q, Childs G, Garg M, Haigentz M, Hogue-Angeletti R, Moadel R, Negassa A, Owen R, Prystowsky MB, Schiff B, Schlecht NF, Shifteh K, Smith RV, Zheng X.

Cytogenet Genome Res. 2007;118(2-4):92-109. No abstract available.

PMID:
18000360
42.

Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue.

Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN.

Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):874-8.

PMID:
16230589
43.

Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer.

Younes MN, Kim S, Yigitbasi OG, Mandal M, Jasser SA, Dakak Yazici Y, Schiff BA, El-Naggar A, Bekele BN, Mills GB, Myers JN.

Mol Cancer Ther. 2005 Aug;4(8):1146-56.

44.
45.

Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788.

Kim S, Schiff BA, Yigitbasi OG, Doan D, Jasser SA, Bekele BN, Mandal M, Myers JN.

Mol Cancer Ther. 2005 Apr;4(4):632-40.

46.

An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.

Kim S, Park YW, Schiff BA, Doan DD, Yazici Y, Jasser SA, Younes M, Mandal M, Bekele BN, Myers JN.

Clin Cancer Res. 2005 Mar 1;11(5):1713-21.

47.

Morbidity and mortality audits: "How to"for family practice.

Yaffe MJ, Gupta G, Still S, Boillat M, Russillo B, Schiff B, Sproule D.

Can Fam Physician. 2005 Feb;51:234-9.

48.

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2004 Dec 15;10(24):8594-602. Erratum in: Clin Cancer Res. 2019 Aug 1;25(15):4862.

49.

Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.

Yigitbasi OG, Younes MN, Doan D, Jasser SA, Schiff BA, Bucana CD, Bekele BN, Fidler IJ, Myers JN.

Cancer Res. 2004 Nov 1;64(21):7977-84.

50.

Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.

Holsinger FC, Doan DD, Jasser SA, Swan EA, Greenberg JS, Schiff BA, Bekele BN, Younes MN, Bucana CD, Fidler IJ, Myers JN.

Clin Cancer Res. 2003 Aug 1;9(8):3183-9.

Supplemental Content

Loading ...
Support Center